GeNeuro SA
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol GNRO:xpar
Currency EUR
Euronext Paris
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About GeNeuro SA
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).
Sector Healthcare
Industry Neurology Biopharmaceuticals
Market Cap 0.000819726bn
Data Provided by 
/ 
/